Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/2/2021
SIETES contiene 93212 citas

 
 
 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ 2015;351:h4183. [Ref.ID 99585]
2.Enlace a cita original Cita con resumen
Bolland MJ, Grey A, Gamble GD, Reid IR. Vitamin D supplementation and falls: a trial sequential meta-analysis. The Lancet Diabetes & Endocrinology 2014;2:573-80. [Ref.ID 97456]
4.Tiene citas relacionadas Cita con resumen
Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:289. [Ref.ID 89035]
5.Tiene citas relacionadas Cita con resumen
Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C, FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009;361:756-65. [Ref.ID 86411]
6. Cita con resumen
Reid IR, Ames R, Mason B, Reid HE, Bacon CJ, Bolland MJ, Gamble GD, Grey A, Horne A. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 2008;168:2276-82. [Ref.ID 84499]
7.Tiene citas relacionadas Cita con resumen
Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, Gamble GD, Grey A, Reid IR. Vascular events in healthy order women receiving calcium supplementation: randomised controlled trial. BMJ 2008;336:262-6. [Ref.ID 82129]
8.Tiene citas relacionadas Cita con resumen
Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, for the HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-22. [Ref.ID 79934]
9.Tiene citas relacionadas
Reid IR, Miller P, Lyles KW, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelanakas K, Luchi M, Richardson P, Hosking D. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 2005;353:898-908. [Ref.ID 74690]
Seleccionar todas
 
 1 a 9 de 9